Voyager Therapeutics (NASDAQ:VYGR) Q4 2018 Results Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Matt Osborne - Vice President-Corporate Affairs, Communications and Investor Relations Andre Turenne - President and Chief Executive Officer Allison Dorval - Chief Financial Officer Conference Call Participants Dane Leone - Raymond James Jackson Harvey - Nomura Laura Christianson - Cowen Jeff Hung - Morgan Stanley Operator Good afternoon, and welcome to the Voyager Therapeutics' Four ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37625 Voyager Therapeutics, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction ...